301 related articles for article (PubMed ID: 33023950)
1. Stromal SNAI2 Is Required for ERBB2 Breast Cancer Progression.
Blanco-Gómez A; Hontecillas-Prieto L; Corchado-Cobos R; García-Sancha N; Salvador N; Castellanos-Martín A; Sáez-Freire MDM; Mendiburu-Eliçabe M; Alonso-López D; De Las Rivas J; Lorente M; García-Casas A; Del Carmen S; Abad-Hernández MDM; Cruz-Hernández JJ; Rodríguez-Sánchez CA; Claros-Ampuero J; García-Cenador B; García-Criado J; Orimo A; Gridley T; Pérez-Losada J; Castillo-Lluva S
Cancer Res; 2020 Dec; 80(23):5216-5230. PubMed ID: 33023950
[TBL] [Abstract][Full Text] [Related]
2. A new role of SNAI2 in postlactational involution of the mammary gland links it to luminal breast cancer development.
Castillo-Lluva S; Hontecillas-Prieto L; Blanco-Gómez A; Del Mar Sáez-Freire M; García-Cenador B; García-Criado J; Pérez-Andrés M; Orfao A; Cañamero M; Mao JH; Gridley T; Castellanos-Martín A; Pérez-Losada J
Oncogene; 2015 Sep; 34(36):4777-90. PubMed ID: 26096931
[TBL] [Abstract][Full Text] [Related]
3. HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.
Huang F; Shi Q; Li Y; Xu L; Xu C; Chen F; Wang H; Liao H; Chang Z; Liu F; Zhang XH; Feng XH; Han JJ; Luo S; Chen YG
Cancer Res; 2018 Nov; 78(21):6073-6085. PubMed ID: 30171053
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression.
Yang Z; Yang X; Xu S; Jin P; Li X; Wei X; Liu D; Huang K; Long S; Wang Y; Sun C; Chen G; Hu J; Meng L; Ma D; Gao Q
Mol Cancer; 2017 Oct; 16(1):163. PubMed ID: 29041931
[TBL] [Abstract][Full Text] [Related]
5. Lysyl Oxidase (LOX) Transcriptionally Regulates SNAI2 Expression and TIMP4 Secretion in Human Cancers.
Boufraqech M; Zhang L; Nilubol N; Sadowski SM; Kotian S; Quezado M; Kebebew E
Clin Cancer Res; 2016 Sep; 22(17):4491-504. PubMed ID: 27029493
[TBL] [Abstract][Full Text] [Related]
6. The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.
Wellberg EA; Johnson S; Finlay-Schultz J; Lewis AS; Terrell KL; Sartorius CA; Abel ED; Muller WJ; Anderson SM
Breast Cancer Res; 2016 Dec; 18(1):131. PubMed ID: 27998284
[TBL] [Abstract][Full Text] [Related]
7. Cell lineage tracing links ERα loss in Erbb2-positive breast cancers to the arising of a highly aggressive breast cancer subtype.
Ding Y; Liu Y; Lee DK; Tong Z; Yu X; Li Y; Xu Y; Lanz RB; O'Malley BW; Xu J
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34006643
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer.
Merlino G; Miodini P; Callari M; D'Aiuto F; Cappelletti V; Daidone MG
Mol Oncol; 2017 Oct; 11(10):1399-1412. PubMed ID: 28672102
[TBL] [Abstract][Full Text] [Related]
9. The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer.
Mendoza-Villanueva D; Balamurugan K; Ali HR; Kim SR; Sharan S; Johnson RC; Merchant AS; Caldas C; Landberg G; Sterneck E
Oncogene; 2016 Dec; 35(48):6166-6176. PubMed ID: 27181204
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine 1-phosphate signaling induces SNAI2 expression to promote cell invasion in breast cancer cells.
Wang W; Hind T; Lam BWS; Herr DR
FASEB J; 2019 Jun; 33(6):7180-7191. PubMed ID: 30844311
[TBL] [Abstract][Full Text] [Related]
11. HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
Desai K; Aiyappa R; Prabhu JS; Nair MG; Lawrence PV; Korlimarla A; Ce A; Alexander A; Kaluve RS; Manjunath S; Correa M; Srinath BS; Patil S; Kalamdani A; Prasad M; Sridhar TS
Tumour Biol; 2017 Mar; 39(3):1010428317695028. PubMed ID: 28349782
[TBL] [Abstract][Full Text] [Related]
12. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
13. LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression.
Montañez-Wiscovich ME; Seachrist DD; Landis MD; Visvader J; Andersen B; Keri RA
Oncogene; 2009 Oct; 28(41):3608-18. PubMed ID: 19648968
[TBL] [Abstract][Full Text] [Related]
14. TGFβ-Activated USP27X Deubiquitinase Regulates Cell Migration and Chemoresistance via Stabilization of Snail1.
Lambies G; Miceli M; Martínez-Guillamon C; Olivera-Salguero R; Peña R; Frías CP; Calderón I; Atanassov BS; Dent SYR; Arribas J; García de Herreros A; Díaz VM
Cancer Res; 2019 Jan; 79(1):33-46. PubMed ID: 30341066
[TBL] [Abstract][Full Text] [Related]
15. MMP1 and MMP11 Expression in Peripheral Blood Mononuclear Cells upon Their Interaction with Breast Cancer Cells and Fibroblasts.
Eiro N; Cid S; Aguado N; Fraile M; de Pablo N; Fernández B; Domínguez F; González LO; Vizoso FJ
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396463
[TBL] [Abstract][Full Text] [Related]
16. The Action of Discoidin Domain Receptor 2 in Basal Tumor Cells and Stromal Cancer-Associated Fibroblasts Is Critical for Breast Cancer Metastasis.
Corsa CA; Brenot A; Grither WR; Van Hove S; Loza AJ; Zhang K; Ponik SM; Liu Y; DeNardo DG; Eliceiri KW; Keely PJ; Longmore GD
Cell Rep; 2016 Jun; 15(11):2510-23. PubMed ID: 27264173
[TBL] [Abstract][Full Text] [Related]
17. Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis.
Mizutani Y; Kobayashi H; Iida T; Asai N; Masamune A; Hara A; Esaki N; Ushida K; Mii S; Shiraki Y; Ando K; Weng L; Ishihara S; Ponik SM; Conklin MW; Haga H; Nagasaka A; Miyata T; Matsuyama M; Kobayashi T; Fujii T; Yamada S; Yamaguchi J; Wang T; Woods SL; Worthley D; Shimamura T; Fujishiro M; Hirooka Y; Enomoto A; Takahashi M
Cancer Res; 2019 Oct; 79(20):5367-5381. PubMed ID: 31439548
[TBL] [Abstract][Full Text] [Related]
18. Glutamine-Directed Migration of Cancer-Activated Fibroblasts Facilitates Epithelial Tumor Invasion.
Mestre-Farrera A; Bruch-Oms M; Peña R; Rodríguez-Morató J; Alba-Castellón L; Comerma L; Quintela-Fandino M; Duñach M; Baulida J; Pozo ÓJ; García de Herreros A
Cancer Res; 2021 Jan; 81(2):438-451. PubMed ID: 33229340
[TBL] [Abstract][Full Text] [Related]
19. Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment.
Sakurai M; Miki Y; Takagi K; Suzuki T; Ishida T; Ohuchi N; Sasano H
Breast Cancer Res; 2017 Jun; 19(1):70. PubMed ID: 28629450
[TBL] [Abstract][Full Text] [Related]
20. The miR-203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK-3β/β-CATENIN signal pathway.
Tian X; Tao F; Zhang B; Dong JT; Zhang Z
IUBMB Life; 2018 Mar; 70(3):224-236. PubMed ID: 29389061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
